Patrick Waller counsels clients in patent prosecution in the biomedical field and has experience in biochemistry, molecular and cellular biology, drug design and discovery, biological manufacturing and processing, structural biology, bioinformatics, and diagnostics. His practice also involves strategic counseling in connection with patent portfolio development, licensing, and third party and competitor intellectual property. He is based in Boston, but also supports clients from the firm's New York office.
Patrick’s doctoral research involved the biochemical and genetic analysis of targeted protein degradation.
Patrick was named a "Life Science Star" by the fourth annual edition of LMG Life Sciences. The LMG Life Sciences guide is based on nearly 1,000 interviews and surveys completed by partners active in the market, interviews with clients and leading lawyers, and review of public information. He was also named a 2018/19 Global IP Star by Managing IP.
Patrick has been repeatedly named to the list of Massachusetts Super Lawyers for his work in the field of intellectual property law. He is also listed in the Intellectual Asset Management (IAM) 1000 World’s Leading Patent Practitioners.
Waller PR, Young DW. (2015) Diagnostic patenting since Myriad: an update. MLO Med Lab Obs. 47(4):46.
Waller PR, Young DW. (2013) After the Myriad decision: do hurdles remain for diagnostics competition? MLO Med Lab Obs. 45(9):46.